ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Jagsonpal Pharmaceuticals held its 47th Annual General Meeting on September 18, 2026. Shareholders transacted business including adoption of financial statements and director appointments.
Jagsonpal Pharmaceuticals Ltd has issued the notice for its 47th Annual General Meeting, scheduled for September 18, 2026, alongside the Annual Report for FY 2025-26.
Jagsonpal Pharmaceuticals has scheduled its 47th AGM for September 18, 2026. The company also confirmed September 04, 2026, as the record date for its previously recommended dividend.
Jagsonpal Pharmaceuticals Limited announced the successful passage of a postal ballot resolution for an equity share buy-back worth ₹40 Crore. Shareholders approved the buy-back of up to 16,00,000 shares at ₹250 per share with a 99.99% majority. The resolution was deemed passed on April 24, 2026.